Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab

Overview of attention for article published in Clinical Gastroenterology and Hepatology, May 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

policy: 1 policy source
patent: 1 patent

guideline: 4 clinical guideline sources

Readers on

mendeley: 127 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

The Availability of Data from Clinical Trials: The Case of Crohn's Disease

Cited by Center for Economic and Policy Research (CEPR) on 01 Jun 2018

The Center for Economic and Policy Research (CEPR) promotes democratic debate on the most important economic and social issues that affect people's lives.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.